Subscribe
eNewsletter
Ready to get certified?
Free CDCES Coach App
Download
Free Med Pocket Cards
eNewsletter
Free CDCES Coach App
Free Med Pocket Cards
Question of the Week: A 62-year-old person with type 2 diabetes has an A1C of 9.1% despite metformin, SGLT-2i and a GLP-1 receptor agonist. You are considering once-weekly insulin icodec … Continue reading Question of the Week | Benefits of Once Weekly Insulin Icodec
Happy April! There is a lot of exciting news contained in this month’s newsletter. The world of diabetes pharmacology is advancing at a breakneck pace, and we are here to … Continue reading April 2026 eNews | Once Weekly Insulin Approved
For last week’s practice question, we quizzed participants on checkpoint inhibitors triggering hyperglycemia. 34% of respondents chose the best answer. We want to clarify and share this important information, so … Continue reading Rationale of the Week | Checkpoint Inhibitors Triggering Hyperglycemia
Question of the Week: KC is a 62-year-old individual with type 2 diabetes who presents for follow-up after initiating a weight loss program 3 months ago. They report consuming approximately … Continue reading Question of the Week | Next Step after 12% Weight Loss?
In diabetes care, what is the reported percentageof patients who have missed or not returned for follow-up care due to feelings of shame, blame, or judgment? 10% Answer A is … Continue reading Rationale of the Week | Common Cause of Missed Appts?
By: Sarah Beattie, DNP, APRN-CNP, CDCES Did you know that in ancient times, diabetes was identified by the sweet taste of a person’s urine? Thankfully, science has come a long … Continue reading Non-Invasive Glucose Monitoring: Update for Clinicians
Betty, a 60-year-old female, is receiving pembrolizumab, an immune checkpoint inhibitor, as treatment for melanoma. She is worried about the potential adverse effects. She is very concerned about the risk … Continue reading Question of the Week | Checkpoint Inhibitors Triggering Hyperglycemia
For last week’s practice question, we quizzed participants on who needs to have a bone density evaluation according to the 2026 ADA Standards. 47% of respondents chose the best answer. … Continue reading Rationale of the Week | Indications for DXA Assessment of Bone Mineral Density